These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9151155)

  • 1. Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-density-lipoprotein apheresis.
    Kojima S; Ogi M; Yoshitomi Y; Kuramochi M; Ikeda J; Naganawa M; Hatakeyama H
    Int J Artif Organs; 1997 Mar; 20(3):178-83. PubMed ID: 9151155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in plasma levels of cyclic nucleotides during low-density lipoprotein apheresis.
    Kojima S; Yoshitomi Y; Sugi T; Matsumoto Y; Yano M; Kuramochi M
    Ther Apher; 1998 Nov; 2(4):263-7. PubMed ID: 10227752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in plasma levels of nitric oxide derivative during low-density lipoprotein apheresis.
    Kojima S; Ogi M; Sugi T; Matsumoto Y; Yoshitomi Y; Kuramochi M
    Ther Apher; 1997 Nov; 1(4):356-61. PubMed ID: 10225731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nafamostat mesilate on bradykinin generation during low-density lipoprotein apheresis using a dextran sulfate cellulose column.
    Kojima S; Harada-Shiba M; Nomura S; Kimura G; Tsushima M; Kuramochi M; Yamamoto A; Omae T
    ASAIO Trans; 1991; 37(4):644-8. PubMed ID: 1768503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of nafamostat mesilate on bradykinin generation and hemodynamics during LDL apheresis.
    Kojima S; Shiba M; Kuramochi M; Yamamoto A
    Artif Organs; 1995 Feb; 19(2):135-9. PubMed ID: 7763192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contact activation in low-density lipoprotein apheresis systems.
    Krieter DH; Steinke J; Kerkhoff M; Fink E; Lemke HD; Zingler C; Müller GA; Schuff-Werner P
    Artif Organs; 2005 Jan; 29(1):47-52. PubMed ID: 15644083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in coagulation factors by passage through a dextran sulfate cellulose column during low-density lipoprotein apheresis.
    Kojima S; Harada-Shiba M; Toyota Y; Kimura G; Tsushima M; Kuramochi M; Sakata T; Uchida K; Yamamoto A; Omae T
    Int J Artif Organs; 1992 Mar; 15(3):185-90. PubMed ID: 1521904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the production of nitric oxide contribute to the early improvement after a single low-density lipoprotein apheresis in patients with peripheral arterial obstructive disease?
    Kizaki Y; Ueki Y; Yoshida K; Yano M; Matsumoto K; Miyake S; Tominaga Y; Eguchi K; Yano K
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):341-9. PubMed ID: 10493215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaphylactoid reactions and bradykinin generation in patients treated with LDL-apheresis and an ACE inhibitor.
    Koga N; Nagano T; Sato T; Kagasawa K
    ASAIO J; 1993; 39(3):M288-91. PubMed ID: 8268545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of losartan on low-density lipoprotein apheresis.
    Kojima S; Yoshitomi Y; Saotome M; Tanaka K; Shida M; Kuramochi M
    Ther Apher; 1999 Nov; 3(4):303-6. PubMed ID: 10608722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two low-density lipoprotein apheresis systems in patients with homozygous familial hypercholesterolemia.
    Drouin-Chartier JP; Tremblay AJ; Bergeron J; Pelletier M; Laflamme N; Lamarche B; Couture P
    J Clin Apher; 2016 Aug; 31(4):359-67. PubMed ID: 26011648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased susceptibility of low-density lipoproteins to in-vitro oxidation after dextran-sulfate LDL-apheresis treatment.
    Leitinger N; Pirich C; Blazek I; Endler G; Sinzinger H
    Atherosclerosis; 1996 Oct; 126(2):305-12. PubMed ID: 8902156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety measures for low density lipoprotein apheresis treatment using dextran sulfate cellulose columns.
    Koga N
    Ther Apher; 1999 May; 3(2):155-60. PubMed ID: 10341391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic systems.
    Knisel W; Di Nicuolo A; Pfohl M; Müller H; Risler T; Eggstein M; Seifried E
    J Intern Med; 1993 Nov; 234(5):479-87. PubMed ID: 8228792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis).
    Mabuchi H; Michishita I; Takeda M; Fujita H; Koizumi J; Takeda R; Takada S; Oonishi M
    Atherosclerosis; 1987 Nov; 68(1-2):19-25. PubMed ID: 2446636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoprotein apheresis and changes in plasma components.
    Kojima S
    Ther Apher; 2001 Aug; 5(4):232-8. PubMed ID: 11724506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of a heparin-citrate anticoagulation for LDL-apheresis in two primary apheresis systems.
    Handschel D; Etienne Janssens M; Gericke M; De Reys S; Borberg H
    J Clin Apher; 2017 Oct; 32(5):319-328. PubMed ID: 27676234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of losartan on blood pressure and humoral factors in a patient who suffered from anaphylactoid reactions when treated with ACE inhibitors during LDL apheresis.
    Kojima S; Shida M; Takano H; Inami S; Yodogawa K; Yokoyama H; Kuramochi M
    Hypertens Res; 2001 Sep; 24(5):595-8. PubMed ID: 11675956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease of thyroid hormones in patients with familial hypercholesterolemia during dextran sulphate low-density lipoprotein apheresis.
    Pintus S; Pintus P; Piras C; Loviselli A; Muntoni S
    J Clin Apher; 1994; 9(2):124-5. PubMed ID: 7798159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of different low density lipoprotein apheresis machines on brain natriuretic Peptide levels in patients with familial hypercholesterolemia.
    Moriarty P; Sosland R; Gibson C; Belmont J
    Ther Apher Dial; 2010 Feb; 14(1):74-8. PubMed ID: 20438521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.